Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes
Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic compl...
Saved in:
| Published in | PloS one Vol. 11; no. 2; p. e0147981 |
|---|---|
| Main Authors | , , , , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Public Library of Science
04.02.2016
Public Library of Science (PLoS) |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects.
In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay.
Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively.
In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. |
|---|---|
| AbstractList | Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. Methods In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Results Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. Conclusions In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. Methods In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Results Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12–2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871–0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. Conclusions In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects.BACKGROUNDDiabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects.In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay.METHODSIn this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay.Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively.RESULTSSubjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively.In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects.CONCLUSIONSIn conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the deamination of primary amines into aldehydes, hydrogen peroxide, and ammonia, both of which are involved in the pathogenesis of diabetic complications. We have shown that serum VAP-1 is higher in patients with diabetes and in patients with chronic kidney disease (CKD), and can predict cardiovascular mortality in subjects with diabetes. In this study, we investigated if serum VAP-1 can predict ESRD in diabetic subjects. In this prospective cohort study, a total of 604 type 2 diabetic subjects were enrolled between 1996 to 2003 at National Taiwan University Hospital, Taiwan, and were followed for a median of 12.36 years. The development of ESRD was ascertained by linking our database with the nationally comprehensive Taiwan Society Nephrology registry. Serum VAP-1 concentrations at enrollment were measured by time-resolved immunofluorometric assay. Subjects with serum VAP-1 in the highest tertile had the highest incidence of ESRD (p<0.001). Every 1-SD increase in serum VAP-1 was associated with a hazard ratio of 1.55 (95%CI 1.12-2.14, p<0.01) for the risk of ESRD, adjusted for smoking, history of cardiovascular disease, body mass index, hypertension, HbA1c, duration of diabetes, total cholesterol, use of statins, ankle-brachial index, estimated GFR, and proteinuria. We developed a risk score comprising serum VAP-1, HbA1c, estimated GFR, and proteinuria, which could predict ESRD with good performance (area under the ROC curve = 0.9406, 95%CI 0.8871-0.9941, sensitivity = 77.3%, and specificity = 92.8%). We also developed an algorithm based on the stage of CKD and a risk score including serum VAP-1, which can stratify these subjects into 3 categories with an ESRD risk of 0.101%/year, 0.131%/year, and 2.427%/year, respectively. In conclusion, serum VAP-1 can predict ESRD and is a useful biomarker to improve risk stratification in type 2 diabetic subjects. |
| Audience | Academic |
| Author | Li, Hung-Yuan Lin, Mao-Shin Lin, Hung-An Kao, Hsien-Li Jiang, Yi-Der Nien, Feng-Jung Hung, Chi-Sheng Chuang, Lee-Ming Wu, Vin-Cent Lin, Cheng-Hsin Chang, Tien-Jyun Shih, Shyang-Rong Wei, Jung-Nan |
| AuthorAffiliation | 1 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan 4 Graduate Institute of Clinical Medicine, Medical College, National Taiwan University, Taipei, Taiwan 5 Chia Nan University of Pharmacy and Science, Tainan, Taiwan 6 Division of Cardiovascular Surgery, Department of Surgery, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan University of Sao Paulo Medical School, BRAZIL 3 Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan 7 Graduate Institute of Preventive Medicine, National Taiwan University School of Public Health, Taipei, Taiwan 2 Lo-Sheng Sanatorium and Hospital, Ministry of Health and Welfare, Taipei, Taiwan |
| AuthorAffiliation_xml | – name: University of Sao Paulo Medical School, BRAZIL – name: 7 Graduate Institute of Preventive Medicine, National Taiwan University School of Public Health, Taipei, Taiwan – name: 1 Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan – name: 2 Lo-Sheng Sanatorium and Hospital, Ministry of Health and Welfare, Taipei, Taiwan – name: 4 Graduate Institute of Clinical Medicine, Medical College, National Taiwan University, Taipei, Taiwan – name: 6 Division of Cardiovascular Surgery, Department of Surgery, Taipei Medical University-Wan Fang Hospital, Taipei, Taiwan – name: 3 Department of Internal Medicine, National Taiwan University Hospital Yun-Lin Branch, Yun-Lin, Taiwan – name: 5 Chia Nan University of Pharmacy and Science, Tainan, Taiwan |
| Author_xml | – sequence: 1 givenname: Hung-Yuan surname: Li fullname: Li, Hung-Yuan – sequence: 2 givenname: Hung-An surname: Lin fullname: Lin, Hung-An – sequence: 3 givenname: Feng-Jung surname: Nien fullname: Nien, Feng-Jung – sequence: 4 givenname: Vin-Cent surname: Wu fullname: Wu, Vin-Cent – sequence: 5 givenname: Yi-Der surname: Jiang fullname: Jiang, Yi-Der – sequence: 6 givenname: Tien-Jyun surname: Chang fullname: Chang, Tien-Jyun – sequence: 7 givenname: Hsien-Li surname: Kao fullname: Kao, Hsien-Li – sequence: 8 givenname: Mao-Shin surname: Lin fullname: Lin, Mao-Shin – sequence: 9 givenname: Jung-Nan surname: Wei fullname: Wei, Jung-Nan – sequence: 10 givenname: Cheng-Hsin surname: Lin fullname: Lin, Cheng-Hsin – sequence: 11 givenname: Shyang-Rong surname: Shih fullname: Shih, Shyang-Rong – sequence: 12 givenname: Chi-Sheng surname: Hung fullname: Hung, Chi-Sheng – sequence: 13 givenname: Lee-Ming surname: Chuang fullname: Chuang, Lee-Ming |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26845338$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk12L1DAUhousuB_6D0QLguhFx-ajSeOFMKyrDiys7Kx7G9L0dCZDpxmTVN1_b8bpyHRZRHrRcPKc9-Q9nHOaHHW2gyR5jvIJIhy9W9nedaqdbGJ4kiPKRYkeJSdIEJwxnJOjg_Nxcur9Ks8LUjL2JDnGrKQFIeVJoufg-nV6q7zuW-XSab0Eb2yXfnU2gOkyFE9QGx18etHV2TyoBaTXECunH40H5SE1kVbBQBeZnyYs05u7DaQ43qsKAvinyeNGtR6eDf-z5Nuni5vzL9nl1efZ-fQy00zgkDWVKhpFakoQwqjmmgPHuWYMQcEBsYpjKGrBOCG0YbxmXBciui5FKQrBgJwlL3e6m9Z6OfTHS8QZZrwoeBmJ2Y6orVrJjTNr5e6kVUb-CVi3kMoFo1uQiDKRA6O4qgkFzStakkbkCNdMYyx01PowVOurNdQ62neqHYmObzqzlAv7Q1JOcV7wKPBmEHD2ew8-yLXxGtpWdWD73bsF29qL6Kt76MPuBmqhogHTNTbW1VtROaUUk7KgOYvU5AEqfjWsjY7D1JgYHyW8HSVEJsCvsFC993I2v_5_9up2zL4-YJeg2rD0tu1DHD8_Bl8cdvpvi_dTHIH3O0A7672DRmoT1FYnWjOtRLncrsy-aXK7MnJYmZhM7yXv9f-Z9hvKGheh |
| CitedBy_id | crossref_primary_10_3389_fimmu_2023_1126348 crossref_primary_10_1177_01455613221074147 crossref_primary_10_3389_fendo_2022_825950 crossref_primary_10_3390_molecules25092029 crossref_primary_10_1038_s41366_018_0172_4 crossref_primary_10_1016_j_celrep_2020_108525 crossref_primary_10_1038_s41581_019_0234_4 crossref_primary_10_1111_jdi_14209 crossref_primary_10_3389_fcell_2021_624184 crossref_primary_10_1371_journal_pone_0284412 crossref_primary_10_22159_ijap_2025v17i1_52956 crossref_primary_10_1007_s43440_021_00343_y crossref_primary_10_1186_s13643_021_01841_z crossref_primary_10_3390_ijms251810051 crossref_primary_10_1093_ndt_gfz018 crossref_primary_10_1039_C7RA12423F crossref_primary_10_1002_dmrr_3556 crossref_primary_10_1016_S2213_8587_18_30289_4 crossref_primary_10_1089_ars_2017_7418 crossref_primary_10_23876_j_krcp_19_063 crossref_primary_10_1097_MD_0000000000021192 crossref_primary_10_1016_j_bcp_2024_116513 crossref_primary_10_3390_ijms21113798 crossref_primary_10_3389_fonc_2023_1308353 crossref_primary_10_1186_s40942_021_00288_7 crossref_primary_10_1016_S2213_8587_18_30304_8 crossref_primary_10_1080_1354750X_2019_1684562 crossref_primary_10_1186_s12933_024_02443_4 crossref_primary_10_1024_0301_1526_a001031 |
| Cites_doi | 10.1111/j.2042-7158.1981.tb13868.x 10.1016/j.jfma.2012.09.006 10.1016/j.clinbiochem.2008.06.019 10.1161/CIRCRESAHA.110.223545 10.1016/j.jfma.2012.09.013 10.3109/10408363.2015.1050714 10.1096/fj.03-0562fje 10.1084/jem.178.6.2255 10.1016/S0021-9150(98)00142-7 10.1111/j.1399-6576.2011.02578.x 10.7326/0003-4819-150-9-200905050-00006 10.1016/j.diabres.2012.11.006 10.1167/iovs.12-9857 10.1681/ASN.2010121224 10.1016/j.cca.2009.03.041 10.1038/ki.2011.259 10.1161/01.CIR.0000033116.22237.F9 10.1001/jama.2011.826 10.1182/blood-2003-09-3275 10.1161/01.RES.0000134630.68877.2F 10.1186/2050-7771-1-9 10.1007/s001250050816 10.1016/j.coph.2015.09.014 10.2174/092986708785133022 10.1681/ASN.2004110961 10.1161/ATVBAHA.111.238030 10.2337/diacare.29.01.06.dc05-1063 10.1007/s00125-004-1346-2 10.1097/MNH.0000000000000072 10.1161/ATVBAHA.107.153130 10.1016/S1570-9639(03)00047-5 10.1155/2015/358086 10.2337/db10-0607 10.2337/diacare.26.12.3333 10.2337/diabetes.54.6.1615 10.4093/dmj.2015.39.3.230 10.1016/S1056-8727(02)00204-0 10.1016/j.cca.2009.01.027 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2016 Public Library of Science 2016 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2016 Li et al 2016 Li et al |
| Copyright_xml | – notice: COPYRIGHT 2016 Public Library of Science – notice: 2016 Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2016 Li et al 2016 Li et al |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0147981 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Gale In Context: Science ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Materials Science & Engineering ProQuest Central (Alumni) ProQuest One Sustainability (subscription) ProQuest Central UK/Ireland Advanced Technologies & Aerospace Collection ProQuest : Agricultural & Environmental Science Collection [unlimited simultaneous users] ProQuest Central Essentials Local Electronic Collection Information ProQuest : Biological Science Collection journals [unlimited simultaneous users] ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agricultural Science Database Health & Medical Collection (Alumni Edition) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition Engineering collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) |
| DocumentTitleAlternate | Serum VAP-1 Predicts ESRD in Diabetes |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1762675578 oai_doaj_org_article_14690e642bd34ec7b483f9012d6c229c PMC4742057 3943545711 A442385406 26845338 10_1371_journal_pone_0147981 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Taiwan Japan |
| GeographicLocations_xml | – name: Taiwan – name: Japan |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PTHSS PV9 PYCSY RNS RPM RZL SV3 TR2 UKHRP WOQ WOW ~02 ~KM CGR CUY CVF ECM EIF IPNFZ NPM PJZUB PPXIY PQGLB RIG BBORY PMFND 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI RC3 7X8 5PM PUEGO AAPBV ABPTK BBAFP |
| ID | FETCH-LOGICAL-c692t-fba5fa3d431121d7c7e720c661e57e16b72e5d967334f67d67c597988989596e3 |
| IEDL.DBID | DOA |
| ISSN | 1932-6203 |
| IngestDate | Sun Oct 02 00:11:14 EDT 2022 Wed Aug 27 01:28:32 EDT 2025 Thu Aug 21 18:21:31 EDT 2025 Fri Jul 11 07:21:37 EDT 2025 Fri Jul 25 11:29:40 EDT 2025 Tue Jun 17 20:58:16 EDT 2025 Tue Jun 10 20:32:28 EDT 2025 Fri Jun 27 03:53:26 EDT 2025 Fri Jun 27 04:40:47 EDT 2025 Thu May 22 21:09:06 EDT 2025 Mon Jul 21 05:53:46 EDT 2025 Tue Jul 01 01:39:42 EDT 2025 Thu Apr 24 23:08:02 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Language | English |
| License | This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c692t-fba5fa3d431121d7c7e720c661e57e16b72e5d967334f67d67c597988989596e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Competing Interests: The authors have declared that no competing interests exist. Conceived and designed the experiments: HYL VCW YDJ LMC. Performed the experiments: HYL VCW YDJ TJC LMC. Analyzed the data: HYL HAL LMC. Contributed reagents/materials/analysis tools: HYL FJN VCW YDJ TJC HLK MSL JNW CHL SRS CSH LMC. Wrote the paper: HYL HAL FJN VCW YDJ TJC HLK MSL JNW CHL SRS CSH LMC. |
| OpenAccessLink | https://doaj.org/article/14690e642bd34ec7b483f9012d6c229c |
| PMID | 26845338 |
| PQID | 1762675578 |
| PQPubID | 1436336 |
| ParticipantIDs | plos_journals_1762675578 doaj_primary_oai_doaj_org_article_14690e642bd34ec7b483f9012d6c229c pubmedcentral_primary_oai_pubmedcentral_nih_gov_4742057 proquest_miscellaneous_1762968898 proquest_journals_1762675578 gale_infotracmisc_A442385406 gale_infotracacademiconefile_A442385406 gale_incontextgauss_ISR_A442385406 gale_incontextgauss_IOV_A442385406 gale_healthsolutions_A442385406 pubmed_primary_26845338 crossref_citationtrail_10_1371_journal_pone_0147981 crossref_primary_10_1371_journal_pone_0147981 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2016-02-04 |
| PublicationDateYYYYMMDD | 2016-02-04 |
| PublicationDate_xml | – month: 02 year: 2016 text: 2016-02-04 day: 04 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2016 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | MW Taal (ref34) 2014; 23 T Narita (ref41) 2006; 29 SK Venugopal (ref27) 2002; 106 CM Stolen (ref5) 2004; 95 F Boomsma (ref23) 2003; 1647 R Pannecoeck (ref8) 2015; 52 A Abella (ref9) 2004; 47 R Lewinsohn (ref6) 1981; 33 WJ Li HY (ref17) 2009; 404 PH Yu (ref31) 1998; 140 ref1 K Koskinen (ref11) 2004; 103 K Aalto (ref33) 2012; 32 I Fernandes-Freitas (ref35) 2015; 25 MS LH Lin (ref19) 2008; 41 D Streja (ref28) 2003; 17 PH Yu (ref13) 1997; 40 C Wang (ref39) 2013; 1 M Salmi (ref7) 1993; 178 ref25 MJ Lee (ref40) 2015; 39 F Giacco (ref30) 2010; 107 J Kendrick (ref38) 2011; 22 M Sallisalmi (ref10) 2012; 56 HY Li (ref2) 2012; 111 ZD Yu PH (ref16) 1997; 40 M Brownlee (ref26) 2005; 54 T Isakova (ref37) 2011; 305 M Dalla Vestra (ref29) 2005; 16 YY Huang (ref3) 2012; 111 P Dunkel (ref42) 2008; 15 L Guariguata (ref4) 2012; 98 C Schnedl (ref36) 2015; 2015 LM Li HY (ref24) 2009; 403 NK Murata M (ref32) 2012; 53 (ref21) 2003; 26 S Jalkanen (ref12) 2008; 28 PH Yu (ref14) 1998; 140 CM Stolen (ref15) 2004; 18 JY Li HY (ref18) 2011; 60 AS Levey (ref20) 2009; 150 VC Wu (ref22) 2011; 80 9862279 - Atherosclerosis. 1998 Oct;140(2):357-63 15938041 - J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S78-82 24252392 - Biomark Res. 2013 Feb 04;1(1):9 23217600 - J Formos Med Assoc. 2012 Nov;111(11):645-50 18644360 - Clin Biochem. 2008 Nov;41(16-17):1362-7 26124993 - Diabetes Metab J. 2015 Jun;39(3):230-9 19361461 - Clin Chim Acta. 2009 May;403(1-2):97-101 6117634 - J Pharm Pharmacol. 1981 Sep;33(9):569-75 22618595 - Invest Ophthalmol Vis Sci. 2012 Jun;53(7):4055-62 14977883 - FASEB J. 2004 Apr;18(6):702-4 21832983 - Kidney Int. 2011 Dec;80(11):1222-30 23217268 - Diabetes Res Clin Pract. 2012 Dec;98(3):524-5 12738395 - J Diabetes Complications. 2003 May-Jun;17(3):120-7 25226275 - Curr Opin Nephrol Hypertens. 2014 Nov;23(6):519-24 22116093 - Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):523-32 15919781 - Diabetes. 2005 Jun;54(6):1615-25 15178639 - Circ Res. 2004 Jul 9;95(1):50-7 21903574 - J Am Soc Nephrol. 2011 Oct;22(10):1913-22 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 12686107 - Biochim Biophys Acta. 2003 Apr 11;1647(1-2):48-54 21030723 - Circ Res. 2010 Oct 29;107(9):1058-70 14968297 - Diabetologia. 2004 Mar;47(3):429-38 17962625 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):18-26 26287391 - Crit Rev Clin Lab Sci. 2015;52(6):284-300 26531325 - Curr Opin Pharmacol. 2015 Dec;25:30-5 26491212 - Dis Markers. 2015;2015:358086 16373913 - Diabetes Care. 2006 Jan;29(1):142-4 12234944 - Circulation. 2002 Sep 17;106(12):1439-41 23217599 - J Formos Med Assoc. 2012 Nov;111(11):637-44 22150439 - Acta Anaesthesiol Scand. 2012 Mar;56(3):316-22 21673295 - JAMA. 2011 Jun 15;305(23):2432-9 21282368 - Diabetes. 2011 Mar;60(3):993-9 19336232 - Clin Chim Acta. 2009 Jun 27;404(2):149-53 18691041 - Curr Med Chem. 2008;15(18):1827-39 8245796 - J Exp Med. 1993 Dec 1;178(6):2255-60 9389414 - Diabetologia. 1997 Nov;40(11):1243-50 14633825 - Diabetes Care. 2003 Dec;26(12):3333-41 14726375 - Blood. 2004 May 1;103(9):3388-95 |
| References_xml | – volume: 33 start-page: 569 issue: 9 year: 1981 ident: ref6 article-title: Amine oxidase in human blood vessels and non-vascular smooth muscle publication-title: J Pharm Pharmacol doi: 10.1111/j.2042-7158.1981.tb13868.x – ident: ref1 – volume: 111 start-page: 637 issue: 11 year: 2012 ident: ref3 article-title: Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of the nationwide data for 2000–2009 publication-title: Journal of the Formosan Medical Association = Taiwan yi zhi doi: 10.1016/j.jfma.2012.09.006 – volume: 41 start-page: 1362 year: 2008 ident: ref19 article-title: Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease publication-title: Clin Biochem doi: 10.1016/j.clinbiochem.2008.06.019 – volume: 107 start-page: 1058 year: 2010 ident: ref30 article-title: Oxidative stress and diabetic complications publication-title: Circ Res doi: 10.1161/CIRCRESAHA.110.223545 – volume: 111 start-page: 645 issue: 11 year: 2012 ident: ref2 article-title: Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000–2009 publication-title: Journal of the Formosan Medical Association = Taiwan yi zhi doi: 10.1016/j.jfma.2012.09.013 – volume: 52 start-page: 284 issue: 6 year: 2015 ident: ref8 article-title: Vascular adhesion protein-1: Role in human pathology and application as a biomarker publication-title: Critical reviews in clinical laboratory sciences doi: 10.3109/10408363.2015.1050714 – volume: 18 start-page: 702 issue: 6 year: 2004 ident: ref15 article-title: Semicarbazide sensitive amine oxidase overexpression has dual consequences: insulin mimicry and diabetes-like complications publication-title: FASEB journal: official publication of the Federation of American Societies for Experimental Biology doi: 10.1096/fj.03-0562fje – ident: ref25 – volume: 178 start-page: 2255 issue: 6 year: 1993 ident: ref7 article-title: Induction and function of vascular adhesion protein-1 at sites of inflammation publication-title: The Journal of experimental medicine doi: 10.1084/jem.178.6.2255 – volume: 140 start-page: 357 issue: 2 year: 1998 ident: ref31 article-title: Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover publication-title: Atherosclerosis doi: 10.1016/S0021-9150(98)00142-7 – volume: 56 start-page: 316 year: 2012 ident: ref10 article-title: Vascular adhesion protein-1 and syndecan-1 in septic shock publication-title: Acta Anaesthesiol Scand doi: 10.1111/j.1399-6576.2011.02578.x – volume: 150 start-page: 604 issue: 9 year: 2009 ident: ref20 article-title: A new equation to estimate glomerular filtration rate publication-title: Annals of internal medicine doi: 10.7326/0003-4819-150-9-200905050-00006 – volume: 98 start-page: 524 year: 2012 ident: ref4 article-title: By the numbers: New estimates from the IDF Diabetes Atlas Update for 2012 publication-title: Diabetes Res Clin Pract doi: 10.1016/j.diabres.2012.11.006 – volume: 53 start-page: 4055 year: 2012 ident: ref32 article-title: Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy publication-title: Invest Ophthalmol Vis Sci doi: 10.1167/iovs.12-9857 – volume: 22 start-page: 1913 issue: 10 year: 2011 ident: ref38 article-title: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis publication-title: Journal of the American Society of Nephrology: JASN doi: 10.1681/ASN.2010121224 – volume: 404 start-page: 149 year: 2009 ident: ref17 article-title: Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia publication-title: Clin Chim Acta doi: 10.1016/j.cca.2009.03.041 – volume: 80 start-page: 1222 issue: 11 year: 2011 ident: ref22 article-title: Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality publication-title: Kidney international doi: 10.1038/ki.2011.259 – volume: 106 start-page: 1439 issue: 12 year: 2002 ident: ref27 article-title: Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells publication-title: Circulation doi: 10.1161/01.CIR.0000033116.22237.F9 – volume: 305 start-page: 2432 issue: 23 year: 2011 ident: ref37 article-title: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease publication-title: JAMA: the journal of the American Medical Association doi: 10.1001/jama.2011.826 – volume: 103 start-page: 3388 issue: 9 year: 2004 ident: ref11 article-title: Granulocyte transmigration through the endothelium is regulated by the oxidase activity of vascular adhesion protein-1 (VAP-1) publication-title: Blood doi: 10.1182/blood-2003-09-3275 – volume: 95 start-page: 50 year: 2004 ident: ref5 article-title: Origins of serum semicarbazide-sensitive amine oxidase publication-title: Circ Res doi: 10.1161/01.RES.0000134630.68877.2F – volume: 1 start-page: 9 issue: 1 year: 2013 ident: ref39 article-title: New urinary biomarkers for diabetic kidney disease publication-title: Biomarker research doi: 10.1186/2050-7771-1-9 – volume: 40 start-page: 1243 year: 1997 ident: ref16 article-title: Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications publication-title: Diabetologia doi: 10.1007/s001250050816 – volume: 25 start-page: 30 year: 2015 ident: ref35 article-title: Metabolic roles of endocrine fibroblast growth factors publication-title: Current opinion in pharmacology doi: 10.1016/j.coph.2015.09.014 – volume: 15 start-page: 1827 issue: 18 year: 2008 ident: ref42 article-title: Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target publication-title: Current medicinal chemistry doi: 10.2174/092986708785133022 – volume: 16 start-page: S78 issue: Suppl 1 year: 2005 ident: ref29 article-title: Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes publication-title: Journal of the American Society of Nephrology: JASN doi: 10.1681/ASN.2004110961 – volume: 32 start-page: 523 issue: 2 year: 2012 ident: ref33 article-title: Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations publication-title: Arteriosclerosis, thrombosis, and vascular biology doi: 10.1161/ATVBAHA.111.238030 – volume: 29 start-page: 142 issue: 1 year: 2006 ident: ref41 article-title: Increased urinary excretions of immunoglobulin g, ceruloplasmin, and transferrin predict development of microalbuminuria in patients with type 2 diabetes publication-title: Diabetes care doi: 10.2337/diacare.29.01.06.dc05-1063 – volume: 47 start-page: 429 issue: 3 year: 2004 ident: ref9 article-title: Adipocytes release a soluble form of VAP-1/SSAO by a metalloprotease-dependent process and in a regulated manner publication-title: Diabetologia doi: 10.1007/s00125-004-1346-2 – volume: 23 start-page: 519 issue: 6 year: 2014 ident: ref34 article-title: Progress in risk prediction for people with chronic kidney disease publication-title: Current opinion in nephrology and hypertension doi: 10.1097/MNH.0000000000000072 – volume: 28 start-page: 18 year: 2008 ident: ref12 article-title: VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.153130 – volume: 1647 start-page: 48 year: 2003 ident: ref23 article-title: Plasma semicarbazide-sensitive amine oxidase in human (patho)physiology publication-title: Biochim Biophys Acta doi: 10.1016/S1570-9639(03)00047-5 – volume: 2015 start-page: 358086 year: 2015 ident: ref36 article-title: FGF23 in Acute and Chronic Illness publication-title: Disease markers doi: 10.1155/2015/358086 – volume: 60 start-page: 993 year: 2011 ident: ref18 article-title: Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes publication-title: Diabetes doi: 10.2337/db10-0607 – volume: 26 start-page: 3333 issue: 12 year: 2003 ident: ref21 article-title: Peripheral arterial disease in people with diabetes publication-title: Diabetes care doi: 10.2337/diacare.26.12.3333 – volume: 140 start-page: 357 year: 1998 ident: ref14 article-title: Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: involvement of semicarbazide-sensitive amine oxidase-mediated methylamine turnover publication-title: Atherosclerosis doi: 10.1016/S0021-9150(98)00142-7 – volume: 54 start-page: 1615 year: 2005 ident: ref26 article-title: The pathobiology of diabetic complications: a unifying mechanism publication-title: Diabetes doi: 10.2337/diabetes.54.6.1615 – volume: 39 start-page: 230 issue: 3 year: 2015 ident: ref40 article-title: Serum Ceruloplasmin Level as a Predictor for the Progression of Diabetic Nephropathy in Korean Men with Type 2 Diabetes Mellitus publication-title: Diabetes & metabolism journal doi: 10.4093/dmj.2015.39.3.230 – volume: 40 start-page: 1243 year: 1997 ident: ref13 article-title: Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications publication-title: Diabetologia doi: 10.1007/s001250050816 – volume: 17 start-page: 120 issue: 3 year: 2003 ident: ref28 article-title: Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus publication-title: Journal of diabetes and its complications doi: 10.1016/S1056-8727(02)00204-0 – volume: 403 start-page: 97 year: 2009 ident: ref24 article-title: Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects publication-title: Clin Chim Acta doi: 10.1016/j.cca.2009.01.027 – reference: 9389414 - Diabetologia. 1997 Nov;40(11):1243-50 – reference: 19336232 - Clin Chim Acta. 2009 Jun 27;404(2):149-53 – reference: 8245796 - J Exp Med. 1993 Dec 1;178(6):2255-60 – reference: 23217268 - Diabetes Res Clin Pract. 2012 Dec;98(3):524-5 – reference: 21832983 - Kidney Int. 2011 Dec;80(11):1222-30 – reference: 26124993 - Diabetes Metab J. 2015 Jun;39(3):230-9 – reference: 14633825 - Diabetes Care. 2003 Dec;26(12):3333-41 – reference: 15178639 - Circ Res. 2004 Jul 9;95(1):50-7 – reference: 24252392 - Biomark Res. 2013 Feb 04;1(1):9 – reference: 26531325 - Curr Opin Pharmacol. 2015 Dec;25:30-5 – reference: 6117634 - J Pharm Pharmacol. 1981 Sep;33(9):569-75 – reference: 15919781 - Diabetes. 2005 Jun;54(6):1615-25 – reference: 19361461 - Clin Chim Acta. 2009 May;403(1-2):97-101 – reference: 12738395 - J Diabetes Complications. 2003 May-Jun;17(3):120-7 – reference: 14726375 - Blood. 2004 May 1;103(9):3388-95 – reference: 26491212 - Dis Markers. 2015;2015:358086 – reference: 22618595 - Invest Ophthalmol Vis Sci. 2012 Jun;53(7):4055-62 – reference: 23217599 - J Formos Med Assoc. 2012 Nov;111(11):637-44 – reference: 22150439 - Acta Anaesthesiol Scand. 2012 Mar;56(3):316-22 – reference: 21673295 - JAMA. 2011 Jun 15;305(23):2432-9 – reference: 21903574 - J Am Soc Nephrol. 2011 Oct;22(10):1913-22 – reference: 26287391 - Crit Rev Clin Lab Sci. 2015;52(6):284-300 – reference: 16373913 - Diabetes Care. 2006 Jan;29(1):142-4 – reference: 14977883 - FASEB J. 2004 Apr;18(6):702-4 – reference: 19414839 - Ann Intern Med. 2009 May 5;150(9):604-12 – reference: 18644360 - Clin Biochem. 2008 Nov;41(16-17):1362-7 – reference: 21282368 - Diabetes. 2011 Mar;60(3):993-9 – reference: 21030723 - Circ Res. 2010 Oct 29;107(9):1058-70 – reference: 17962625 - Arterioscler Thromb Vasc Biol. 2008 Jan;28(1):18-26 – reference: 23217600 - J Formos Med Assoc. 2012 Nov;111(11):645-50 – reference: 12686107 - Biochim Biophys Acta. 2003 Apr 11;1647(1-2):48-54 – reference: 18691041 - Curr Med Chem. 2008;15(18):1827-39 – reference: 14968297 - Diabetologia. 2004 Mar;47(3):429-38 – reference: 25226275 - Curr Opin Nephrol Hypertens. 2014 Nov;23(6):519-24 – reference: 9862279 - Atherosclerosis. 1998 Oct;140(2):357-63 – reference: 12234944 - Circulation. 2002 Sep 17;106(12):1439-41 – reference: 15938041 - J Am Soc Nephrol. 2005 Mar;16 Suppl 1:S78-82 – reference: 22116093 - Arterioscler Thromb Vasc Biol. 2012 Feb;32(2):523-32 |
| SSID | ssj0053866 |
| Score | 2.3458683 |
| Snippet | Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and catalyzes the... Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and... Background Diabetes is the leading cause of end-stage renal disease (ESRD) worldwide. Vascular adhesion protein-1 (VAP-1) participates in inflammation and... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e0147981 |
| SubjectTerms | Adhesion Aged Aldehydes Amine Oxidase (Copper-Containing) - blood Amines Ammonia Ankle Atherosclerosis Biology and Life Sciences Biomarkers Body mass Body mass index Body size Cardiovascular diseases Cell adhesion molecules Cell Adhesion Molecules - blood Cholesterol Chronic illnesses Chronic kidney failure Clinical medicine Comorbidity Complications Deamination Diabetes Diabetes mellitus Diabetes mellitus (non-insulin dependent) Diabetes Mellitus, Type 2 - blood Diabetes Mellitus, Type 2 - complications Diabetes Mellitus, Type 2 - epidemiology Diabetes Mellitus, Type 2 - mortality Diabetic retinopathy Diagnosis End-stage renal disease Female Fibroblasts Follow-Up Studies Genetic aspects Glucose Health aspects Health care Hemoglobin Hospitals Humans Hydrogen Hydrogen peroxide Hypertension Internal medicine Kaplan-Meier Estimate Kidney diseases Kidney Failure, Chronic - diagnosis Kidney Failure, Chronic - epidemiology Kidney Failure, Chronic - etiology Kidney Failure, Chronic - mortality Male Medicine and Health Sciences Metabolism Middle Aged Mortality Nephrology Pathogenesis Patients Physiological aspects Preventive medicine Prognosis Proportional Hazards Models Prospective Studies Proteins Proteinuria Risk Risk Factors Smoking Statins Taiwan - epidemiology Type 2 diabetes |
| SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegvPCCGF_LGGAQEvDgbbEdO35CBTYNJD402NS3yLGdrtJIytL-_9wlbiBoAt6q-hK1d77z787nnwl5brkuDbeKecdLJsvgmQUUy0xWCet0WkmLBf2Pn9Txqfwwy2ax4NbGtspNTOwCtW8c1sj3U_BaALcwwV4vfzC8NQp3V-MVGtfJDaQuw5YuPRsSLvBlpeJxOaHT_WidvWVThz1IDbTJ09Fy1LH2D7F5srxo2quA55_9k78tSEe3ya2IJOm0N_0WuRbqO2Qr-mpLX0ZC6Vd3iYOAsP5Oz2LTKZ3684BFMvoFSRoWNUvhE27YrFp6WHsGAHQe6EnA17_rN3DoAqR7CtaWYu2WYgJLOY0dNe09cnp0-O3tMYuXKzCnDF-xqrRZZYUHAJHy1Gung-YHDpbrkOmQqlLzkHmjtBCyUtor7SD3MDleN5kZFcR9MqlBkduEVhBRA7eVBbAoldSl9Va4vMoh-wUEYBIiNjouXGQexwswLopuO01DBtKrrEDLFNEyCWHDU8ueeeMf8m_QfIMs8mZ3XzSX8yK6ISY65iBAzlV6IYPTpcxFBZCIe-U4Ny4hT9D4RX8IdfD-YioBduaAblVCnnUSyJ1RY3PO3K7btnj_-ew_hL6ejIReRKGqAXU4Gw9EwH9CTq6R5O5IEiKAGw1v41TdaKUtfvkKPLmZvlcPPx2G8aXYcFeHZt3LGIXWTsiDfrYPmkWCIMgSYESP_GCk-vFIvTjvqMullhwyhJ2__6yH5Cbg0r45Xu6SyepyHR4B9luVjzsH_wk33lgS priority: 102 providerName: ProQuest – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fb9MwELam8sILYvxaxgYGIQEPqRbHseMHhApsGkgDNOi0t8ixna5SSbqmleC_5y5xIoKK4IG3Kj5H6p3v_F18_o6QZ5rJXDEtQmtYHvLc2VADig1VUsTayKjgGj_on30Up1P-4TK53CFdz1avwHpraof9pKarxfj79Y_X4PCvmq4NMuomjZdV6cYA-aXCu9g3YG-S6KpnvD9XAO8Wwl-g-9PMwQbV8Pj30Xq0XFT1Nij6e0XlL1vUyW1yy2NLOmkXwy7ZceUdsuu9t6YvPMX0y7vEQIjYfKMXvgyVTuyVw89m9DPSNszLMIJfeISzrulxaUOApDNHzx2-_l17pEPnIN2SstYUv-ZSTGkpo77Gpr5HpifHX9-ehr7dQmiEYuuwyHVS6NgCpIhYZKWRTrIjAxu4S6SLRC6ZS6wSMo55IaQV0kA2olJsQJko4eL7ZFSCIvcILSDGOqYLDfCRCy5zbXVs0iKFfBgwgQpI3Ok4M56LHFtiLLLmgE1CTtKqLEPLZN4yAQn7WcuWi-Mv8m_QfL0sMmk3D6rVLPOOiamPOnKQheU25s7InKdxASCJWWEYUyYgj9H4WXsttY8H2YQDEE0B74qAPG0kkE2jxHKdmd7Udfb-08U_CH05Hwg990JFBeow2l-RgP-ELF0DyYOBJMQEMxjew6XaaaXOItjzIDWE8Awzu-W7ffhJP4wvxRK80lWbVkYJtHZAHrSrvdcsUgZB3gAjcuAHA9UPR8r5VUNmziVnkDPs_w9bPSQ3Ac-2RfX8gIzWq407BMy4zh81YeAn4mVqfA priority: 102 providerName: Scholars Portal |
| Title | Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26845338 https://www.proquest.com/docview/1762675578 https://www.proquest.com/docview/1762968898 https://pubmed.ncbi.nlm.nih.gov/PMC4742057 https://doaj.org/article/14690e642bd34ec7b483f9012d6c229c http://dx.doi.org/10.1371/journal.pone.0147981 |
| Volume | 11 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELegvPCCGF8LjGIQEvCQbXYcO3nsRstA2pgKm_oWObazVRpptbT__-5iN1rQpPHAi1X1LlF7d74P-_wzIR81V2XOtYyt4WUsSmdjDVlsnKdVoo1ildC4oH98Io_OxI9ZOrt11Rf2hHl4YC-4PYb1m4MsubSJcEaVIksqCGLcSsN5btD7QszbFFPeB8MsljIclEsU2wt62V0uarcLRYHKM9YLRC1ef-eVB8urRXNXyvl35-StUDR5Sp6EHJKO_G_fIg9c_YxshVna0M8BSvrLc2LAFaz_0PPQbkpH9tLh8hg9RXiGeR0z-IRbNauGjmsbQ-p54ejU4eu_-q0bOgduD77aUFy1pVi6Uk5DL03zgpxNxr8Pj-JwrUJsZM5XcVXqtNKJhdSBcWaVUU7xfQOB2qXKMVkq7lKbS5UkopLKSmWg6sgzvGgyzaVLXpJBDYLcJrQCX-q4rjSkiUIKVWqrE5NVGdS9EPvziCQbGRcmYI7j1RdXRbuRpqD28CIrUDNF0ExE4u6ppcfcuIf_ANXX8SJidvsF2FER7Ki4z44i8g6VX_jjp928L0YCEs4M8loZkQ8tB6Jm1NiWc6HXTVN8_3n-D0y_pj2mT4GpWoA4jA5HIeA_IRpXj3Onxwlz3_TI22iqG6k0BYPYBiUguGF4cmO-d5Pfd2R8Kbba1W6x9jy5RG1H5JW39k6yCA0E9QFQVG8e9ETfp9Tzyxa0XCjBoTZ4_T909YY8hrzVN8-LHTJYXa_dW8gNV-WQPFQzBWN2yHCcfBuSRwfjk9PpsHUQMB6L7AYrQGTb |
| linkProvider | Directory of Open Access Journals |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGeYAXtPG1ssEMAgEP2RrHsZsHhArb1LIP0NimvmWO7XSVRlKWVoh_ir-Ru8QJBE3Ay96q-my19-Xf2ec7Qp4rJpOIKeEZzRKPJ9Z4ClCsF4VpoLT0U67wQP_gUAxP-IdxOF4iP-q3MJhWWfvE0lGbXOMZ-ZYPVgvgFhTs7eyrh12j8Ha1bqFRqcWe_f4NQrbizWgb5PuCsd2d4_dDz3UV8LSI2NxLExWmKjCwc_rMN1JLK1lPwz5lQ2l9kUhmQxMJGQQ8FdIIqQF0R33ssxhGwgaw7g1yE6b30KLkuAnwwHcI4Z7nBdLfctqwOcszuwmhCCzit7a_sktAsxd0Zhd5cRXQ_TNf87cNcHeZ3HHIlQ4qVVshSza7S1acbyjoK1fA-vU9osEBLb7QU5fkSgfm3OKhHP2ERSGmmefDJ7wgmhd0JzMeAN6JpUcWl9-uLozoFKirkq8FxbNiigEzZdRl8BT3ycm1sP0B6WTAyFVCU_DglqlUATjlgstEGRXoftqHaBsQR9QlQc3jWLtK59hw4yIur-8kRDwVy2KUTOwk0yVeM2tWVfr4B_07FF9Di3W6yy_yy0nszB4Dq6hnIcZLTMCtlgnvBylAMGaEZizSXbKBwo-rR6-Nt4kHHGBuH9C06JJnJQXW6sgwGWiiFkURjz6e_gfR56MW0UtHlObADq3cAwz4T1gDrEW53qIEj6Nbw6uoqjVXiviXbcLMWn2vHn7aDOOimOCX2XxR0UQCpd0lDyttbziLBYkgKoER2bKDFuvbI9n0vCyVziVnEJE8-vvP2iC3hscH-_H-6HBvjdwGTFwl5vN10plfLuxjwJ3z5Elp7JScXbd3-QnvnZND |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGkRAvaONrhcEMAgEPWRfHsZsHhApdtTIY09imvgXHdrpKW1KWVoh_jb-Ou8QJBE3Ay96i-mKl9-Xf2ec7Qp4pJpOIKeEZzRKPJ9Z4ClCsF4VpoLT0U65wQ__jvtg95u8n4WSF_KjvwmBaZe0TS0dtco175D0frBbALShYL3VpEQfD0Zv5Vw87SOFJa91Oo1KRPfv9G4RvxevxEGT9nLHRztG7Xc91GPC0iNjCSxMVpiowsIr6zDdSSyvZtoY1y4bS-iKRzIYmEjIIeCqkEVIDAI_62HMxjIQNYN5r5LoMQh9tTE6aYA_8iBDuql4g_Z7TjK15ntktCEtgEr-1FJYdA5p1oTM_y4vLQO-fuZu_LYajVXLLoVg6qNRujazY7DZZc36ioC9dMetXd4gGZ7Q8pycu4ZUOzKnFDTp6gAUiZpnnwxMeFi0KupMZD8Dv1NJDi9MPq8MjOgPqqvxrQXHfmGLwTBl12TzFXXJ8JWy_RzoZMHKd0BS8uWUqVQBUueAyUUYFup_2IfIG9BF1SVDzONau6jk23ziLy6M8CdFPxbIYJRM7yXSJ17w1r6p-_IP-LYqvocWa3eUP-cU0di4Ag6xo20K8l5iAWy0T3g9SgGPMCM1YpLtkE4UfVxdgG88TDzhA3j4ga9ElT0sKrNuRoQVM1bIo4vGnk_8g-nzYInrhiNIc2KGVu4wB_wnrgbUoN1qU4H10a3gdVbXmShH_slN4s1bfy4efNMM4KSb7ZTZfVjSRQGl3yf1K2xvOYnEiiFBgRLbsoMX69kg2Oy3LpnPJGUQnD_7-WZvkBviV-MN4f-8huQnwuMrR5xuks7hY2kcAQRfJ49LWKfly1c7lJwfHl3k |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Serum+Vascular+Adhesion+Protein-1+Predicts+End-Stage+Renal+Disease+in+Patients+with+Type+2+Diabetes&rft.jtitle=PloS+one&rft.au=Hung-Yuan+Li&rft.au=Hung-An+Lin&rft.au=Feng-Jung+Nien&rft.au=Vin-Cent+Wu&rft.date=2016-02-04&rft.pub=Public+Library+of+Science+%28PLoS%29&rft.eissn=1932-6203&rft.volume=11&rft.issue=2&rft.spage=e0147981&rft_id=info:doi/10.1371%2Fjournal.pone.0147981&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_14690e642bd34ec7b483f9012d6c229c |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |